European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Life Sciences & Pharma

Innovation in Animal Health: Turning Potential into Progress

October 14, 2025

Executive Insights

Life Sciences & Pharma

L.E.K. Consulting’s Clinical and eClinical Pharma Services Outlook

June 13, 2025

Executive Insights

Life Sciences & Pharma

Advanced In Vitro Models: Opportunities and Challenges for US Drug Development

May 7, 2025

Executive Insights

Life Sciences & Pharma

Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies

April 17, 2025

Life Sciences & Pharma

Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations

March 10, 2025

Executive Insights

Life Sciences & Pharma

Redefining Biopharma R&D Productivity: New Insights and Strategies

January 9, 2025